Clinical Pathology Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Nephrology Unit, Internal Medicine Department, Mansoura Faculty of Medicine, Mansoura, Egypt.
Infect Disord Drug Targets. 2021;21(2):243-247. doi: 10.2174/1871526520666200520112319.
The aim of the present study was to study the prevalence of plasmid-mediated quinolone resistance (PMQR) genes (qnrA, qnrB, qnrC, qnrD, qnrS, qepA, oqxA, oqxB and aac) in Escherichia coli (E. coli) isolated from patients with nosocomial urinary tract infections (UTIs) and its relation to the extended-spectrum β-lactamase (ESBL) production. ; Methods: A cross-sectional study was carried out on 200 non-duplicated isolates of E. coli isolated from patients with nosocomial UTIs. E.coli isolates were subjected to antibiotic susceptibility testing by disc diffusion method, determination of minimum inhibitory concentrations (MICs) of ciprofloxacin by Epsillometer (E) test strips, detection of ESBL production by double disc synergy method and detection of qnrA, qnrB, qnrC, qnrD, qnrS, qepA, oqxA, oqxB and aac genes by polymerase chain reaction (PCR). ; Results: The antimicrobial susceptibility testing of the isolated E. coli revealed a high frequency of resistance to ampicillin (73.5%), ceftazidime (72%) and imipenem (71.5%). The less frequent resistance was for aztreonam (21.5%), amikacin (36.5%) and gentamicin (38.5%). ESBL production was found in 131 isolates (65.5%) and phenotypic quinolone resistance was detected by MIC in 65 isolates (32.5%), with 52.3% of them showed high resistance to ciprofloxacin with an MIC more than 32 μg/ml. PMQR genes were found in 40 isolates. The frequency of the detected genes was 40%, 37.5%, 35%, 20% and 5% for qnrA, qnrS, qepA, qnrB and oqxA, respectively. Significant association was found between the presence of PMQR genes and ESBL production (P=0.0001). ; Conclusion: The study highlights the prevalence of PMQR genes in E. coli with high association with the ESBL phenotype. This finding is a sign of limited therapeutic options for E. coli.
本研究旨在研究质粒介导的喹诺酮类药物耐药性(PMQR)基因(qnrA、qnrB、qnrC、qnrD、qnrS、qepA、oqxA、oqxB 和 aac)在医院获得性尿路感染(UTI)患者分离的大肠埃希菌(E. coli)中的流行情况及其与产超广谱β-内酰胺酶(ESBL)的关系。
对 200 例医院获得性 UTI 患者分离的非重复大肠埃希菌进行了横断面研究。采用纸片扩散法进行药敏试验,E 试验条测定环丙沙星的最小抑菌浓度(MIC),双碟协同法检测 ESBL 产生情况,聚合酶链反应(PCR)检测 qnrA、qnrB、qnrC、qnrD、qnrS、qepA、oqxA、oqxB 和 aac 基因。
分离的大肠埃希菌的抗菌药敏试验显示对氨苄西林(73.5%)、头孢他啶(72%)和亚胺培南(71.5%)的耐药率较高。较少的耐药性见于氨曲南(21.5%)、阿米卡星(36.5%)和庆大霉素(38.5%)。131 株(65.5%)产 ESBL,65 株(32.5%)通过 MIC 检测出表型喹诺酮耐药性,其中 52.3%对环丙沙星的 MIC 大于 32μg/ml,表现出高度耐药。40 株检测到 PMQR 基因。检测到的基因频率分别为 qnrA、qnrS、qepA、qnrB 和 oqxA 的 40%、37.5%、35%、20%和 5%。PMQR 基因的存在与 ESBL 表型之间存在显著相关性(P=0.0001)。
本研究强调了大肠埃希菌中 PMQR 基因的流行情况,且与 ESBL 表型高度相关。这一发现表明大肠埃希菌的治疗选择有限。